Olive Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.75 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth 7.15%
- Profit Growth 44.57%
- Ebitda -20.56%
- Net Worth 11.29%
- Total Assets -7.43%
About Olive Diagnostics
Olive Diagnostics Private Limited (ODPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2014 and has a history of Ten years and 11 months. Its registered office is in Raigarh, Chattisgarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.75 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Seema Gupta, Akash Sharma, Priyanka Sharma, and One other member serve as directors at the Company.
Company Details
- Location
Raigarh, Chattisgarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110CT2014PTC001335
- Company No.
001335
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Olive Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Gupta  | Director | 24-Mar-2014 | Current |
| Akash Sharma | Director | 01-Dec-2021 | Current |
| Priyanka Sharma | Director | 01-Dec-2021 | Current |
| Manisha Sharma | Director | 24-Mar-2014 | Current |
Financial Performance of Olive Diagnostics.
Olive Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.15% increase. The company also saw a substantial improvement in profitability, with a 44.57% increase in profit. The company's net worth Soared by an impressive increase of 11.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olive Diagnostics?
In 2023, Olive Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹20.00 M
Charges Breakdown by Lending Institutions
- Union Bank Of India : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2014 | Union Bank Of India | ₹2.00 Cr | Satisfied |
How Many Employees Work at Olive Diagnostics?
Unlock and access historical data on people associated with Olive Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olive Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olive Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.